Edgen Stock·Sep 27 2025, 13:17戻る
戻る
Regeneron Pharmaceuticals Reports Strong Q2 2025 Performance Driven by Key Product Growth and R&D Progress
Edgen Stock·Sep 27 2025, 13:17
[1] Regeneron Stock: Strong R&D Pipeline Drives Growth Outlook (NASDAQ:REGN) | Seeking Alpha (https://seekingalpha.com/article/4826353-rege ...)[2] Regeneron Q2 2025 slides: revenue rebounds to $3.68B after Q1 miss - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)[3] Regeneron Stock: Strong R&D Pipeline Drives Growth Outlook (NASDAQ:REGN) (https://vertexaisearch.cloud.google.com/groun ...)